MarketFriction

Shree Ganesh Biotech India Ltd

BSE 539470 · Biotechnology
₹0.47 +0.00%
BSE close2026-10-01
Market cap₹19.1 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales4.124.123.783.561.9814.413.011.380.770.702.121.43
Expenses4.044.034.303.691.9613.944.431.471.170.752.552.32
Operating Profit0.080.09-0.52-0.130.020.47-1.42-0.09-0.40-0.05-0.43-0.89
OPM %1.94%2.18%-13.76%-3.65%1.01%3.26%-47.18%-6.52%-51.95%-7.14%-20.28%-62.24%
Other Income0.000.001.060.370.300.300.470.420.410.370.280.32
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax0.080.090.540.240.320.77-0.950.330.010.32-0.15-0.57
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit0.080.090.540.240.320.77-0.950.330.010.32-0.15-0.57
EPS in Rs0.000.000.010.010.010.02-0.020.010.000.01-0.00-0.01
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2.128.547.865.872.4717.2172.6462.4520.2822.964.975.02
Expenses1.474.784.364.082.2316.5069.1960.3020.4823.925.616.79
Operating Profit0.653.763.501.790.240.713.452.15-0.20-0.96-0.64-1.77
OPM %30.66%44.03%44.53%30.49%9.72%4.13%4.75%3.44%-0.99%-4.18%-12.88%-35.26%
Other Income0.040.000.000.000.00-0.280.050.561.061.351.151.38
Interest0.070.030.000.000.000.000.000.000.000.000.000.00
Depreciation0.070.000.000.000.000.000.000.000.000.000.000.00
Profit before tax0.553.733.501.790.240.433.502.710.860.390.51-0.39
Tax %1.82%0.00%0.00%0.00%0.00%25.58%27.71%25.09%26.74%28.21%27.45%
Net Profit0.543.733.501.790.240.322.532.040.620.280.38-0.39
EPS in Rs0.151.010.950.040.010.010.060.050.020.010.010.00
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth9%-22%-57%-76%
Compounded Profit Growth1%3%-33%-183%
Stock Price CAGR%-42%-18%-39%
Return on Equity3%2%1%1%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital1.831.831.831.8319.9319.9319.9319.9339.8639.8639.8639.86
Reserves2.412.9417.5421.0437.3137.5437.8640.3922.4923.1223.3923.77
Borrowings0.610.500.060.190.190.190.190.000.000.000.000.00
Other Liabilities0.120.030.013.306.667.0616.6433.2417.1810.640.240.17
Total Liabilities4.975.3019.4426.3664.0964.7274.6293.5679.5373.6263.4963.80
Fixed Assets2.402.320.000.000.010.000.000.000.000.000.000.00
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.210.210.000.000.000.003.063.220.000.009.159.15
Other Assets2.362.7719.4426.3664.0864.7271.5690.3479.5373.6254.3454.65
Total Assets4.975.3019.4426.3664.0964.7274.6293.5679.5373.6263.4963.80
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-0.07-0.04-12.942.23-0.50-1.012.363.5710.5410.16-10.21-8.20
Cash from Investing Activity-0.110.002.53-2.36-32.070.99-2.36-3.37-10.09-10.219.808.19
Cash from Financing Activity0.28-0.1110.420.1332.580.000.00-0.190.000.000.000.00
Net Cash Flow0.10-0.160.020.000.01-0.020.010.010.44-0.05-0.410.00
Free Cash Flow-0.07-0.04-10.622.23-0.51-1.012.363.5710.5410.16-10.21-8.20
CFO/OP-14%-6%-344%64%-28%-421%348%132%522%-5,080%1,052%1,259%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days260.71456.25384.23627.841,191.383,072.21601.05220.54112.9859.390.000.00
Inventory Days483.240.000.000.000.000.000.000.000.000.0046.59846.14
Days Payable46.270.000.00
Cash Conversion Cycle697.69456.25384.23627.841,191.383,072.21601.05220.54112.9859.3946.59846.14
Working Capital Days310.68380.50383.81475.99779.122,036.32249.2053.7112.80-132.1150.08860.72
ROCE %9.04%12.25%30.45%16.47%4.45%0.42%1.23%5.92%4.42%1.37%0.76%1.31%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
FIIs2.17%2.17%1.42%1.42%1.42%1.42%1.42%1.42%1.42%1.42%1.42%1.42%
Public97.83%97.84%98.57%98.58%98.57%98.58%98.58%98.58%98.58%98.58%98.59%98.59%
No. of Shareholders78,0961,39,8801,76,7221,81,1981,85,3351,92,0401,95,4351,92,2351,89,3751,86,1481,83,6581,81,722

Fundamentals

Market Cap₹ 19.1 Cr.
Current Price₹ 0.48
Book Value₹ 1.60
ROCE1.31 %
ROE0.96 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)-76%
Compounded Profit Growth (TTM)-183%
Standalone figures.
Valuation
Market capRs 19 Cr
Enterprise valueRs 19 Cr
Price to book0.29x
Price to sales3.73x
EV / sales3.73x
Earnings yield-2.08%
P/E, 3-year average84.09x
P/B, 3-year average0.52x
P/E, 5-year average61.77x
P/B, 5-year average0.75x
Profitability
Operating margin (excl. other income)-12.88%
Operating margin (incl. other income)10.26%
EBITDA margin-7.77%
Pre-tax margin-7.77%
Net profit margin-7.77%
Net margin, latest quarter-39.86%
ROE0.60%
ROCE0.80%
ROA0.60%
ROE, 3-year average0.68%
ROCE, 3-year average0.93%
ROA, 3-year average0.61%
ROE, 5-year average1.93%
ROCE, 5-year average2.63%
ROA, 5-year average1.44%
ROIC (approx.)-0.44%
Tax rate27.45%
Other income / net worth1.81%
Growth
Sales growth (latest year)-78.35%
Profit growth (latest year)35.71%
Sales CAGR, 3 years-56.99%
Sales CAGR, 5 years-22.00%
Profit CAGR, 3 years-42.89%
Profit CAGR, 5 years3.50%
Sales growth QoQ-32.55%
Sales growth YoY (latest quarter)3.62%
Profit growth YoY (latest quarter)-272.73%
Per share
EPS (TTM)Rs -0.01
EPS (latest year)Rs 0.01
EPS (latest quarter)Rs -0.01
EPS, 3-year averageRs 0.01
EPS, 5-year averageRs 0.04
Book value per shareRs 1.60
Sales per shareRs 0.13
Cash flow per shareRs -0.21
Free cash flow per shareRs -0.21
Efficiency
Asset turnover0.08x
Inventory turnover0.43x
Inventory days846 days
Creditor days0 days
Cash conversion cycle846 days
Working capital days861 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Owners' fund to total sources99.73%
Cash flow
Cash from Operating Activity (latest year)Rs -8 Cr
Cash from Investing Activity (latest year)Rs 8 Cr
Free cash flow (latest year)Rs -8 Cr
Cash from ops / profit, 5 years1.00x
Statement figures
Net sales (TTM)Rs 5 Cr
Net sales (latest year)Rs 5 Cr
Sales (latest quarter)Rs 1 Cr
Operating profit excl. other income (latest year)Rs -1 Cr
Operating profit (latest quarter)Rs -1 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs -1 Cr
Cost of goods sold (latest year)Rs 5 Cr
Total expenditure (latest year)Rs 6 Cr
Total income (latest year)Rs 6 Cr
Share capitalRs 40 Cr
ReservesRs 24 Cr
Shareholders' fundsRs 64 Cr
Total assetsRs 64 Cr
InvestmentsRs 9 Cr
InventoryRs 12 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)39.86
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.29 is the lowest in 9.0 years (median 1.99).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period539470Nifty 50Difference
1 week-2.1%-2.8% +0.7 pts
1 month-7.8%-6.8% -1.1 pts
3 months-16.1%-7.6% -8.5 pts
3 years-44.0%+14.2% -58.2 pts
5 years-93.4%+27.9% -121.3 pts

Red flags

F-score 4 of 8
explainWeak cash conversion Cash from operations was -645% of net profit over the last 3 years
explainHigh accruals Profit exceeded operating cash by 13% of total assets in 2026
lookInventory outrunning sales Inventory grew 306% vs sales -78% in 2026
lookProfit leans on other income Other income was 225% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹1 Cr +3.6% vs Jun 2025. Net loss ₹1 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Anthem Biosciences Ltd48,99682.630.4 %
Advanced Enzyme Technologies Ltd3,15220.014.0 %
CCME Global Ltd208-2.92 %
Vivo Bio Tech Ltd367.74 %
Genomic Valley Biotech Ltd98861.02 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Shree Ganesh Biotech India Ltd?

Shree Ganesh Biotech India Ltd (539470) has a market capitalisation of Rs 19.1 Cr. at the 2026-10-01 close.

What were Shree Ganesh Biotech India Ltd's latest quarterly results?

In the Jun 2026 quarter, Shree Ganesh Biotech India Ltd sales was Rs 1 Cr (+3.6% vs Jun 2025) with a net loss of Rs 1 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03